GB9706295D0 - Lamivudine formulation - Google Patents

Lamivudine formulation

Info

Publication number
GB9706295D0
GB9706295D0 GBGB9706295.4A GB9706295A GB9706295D0 GB 9706295 D0 GB9706295 D0 GB 9706295D0 GB 9706295 A GB9706295 A GB 9706295A GB 9706295 D0 GB9706295 D0 GB 9706295D0
Authority
GB
United Kingdom
Prior art keywords
lamivudine
formulation
lamivudine formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9706295.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline SpA
Original Assignee
Glaxo Wellcome SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome SpA filed Critical Glaxo Wellcome SpA
Priority to GBGB9706295.4A priority Critical patent/GB9706295D0/en
Publication of GB9706295D0 publication Critical patent/GB9706295D0/en
Priority to TW087103841A priority patent/TW536403B/en
Priority to US09/044,896 priority patent/US6004968A/en
Priority to SI9830767T priority patent/SI0969815T1/xx
Priority to HN1998000045A priority patent/HN1998000045A/en
Priority to DK98919120T priority patent/DK0969815T3/en
Priority to ES98919120T priority patent/ES2239802T3/en
Priority to EP98919120A priority patent/EP0969815B1/en
Priority to KR10-1999-7008690A priority patent/KR100484695B1/en
Priority to CA002286126A priority patent/CA2286126C/en
Priority to PA19988449301A priority patent/PA8449301A1/en
Priority to AT98919120T priority patent/ATE295150T1/en
Priority to EEP199900440A priority patent/EE03996B1/en
Priority to PE1998000203A priority patent/PE61699A1/en
Priority to CZ0340399A priority patent/CZ298008B6/en
Priority to IDW991096A priority patent/ID29294A/en
Priority to JP54442598A priority patent/JP3264937B2/en
Priority to MYPI98001227A priority patent/MY116242A/en
Priority to PL98336038A priority patent/PL190505B1/en
Priority to SV1998000040A priority patent/SV1998000040A/en
Priority to IL13809898A priority patent/IL138098A/en
Priority to IL13191798A priority patent/IL131917A0/en
Priority to CNB988051222A priority patent/CN1191061C/en
Priority to PCT/EP1998/001626 priority patent/WO1998042321A2/en
Priority to HU0002982A priority patent/HU225600B1/en
Priority to UA99095237A priority patent/UA60328C2/en
Priority to APAP/P/1999/001657A priority patent/AP1141A/en
Priority to YUP-477/99A priority patent/RS49772B/en
Priority to NZ337798A priority patent/NZ337798A/en
Priority to AU72084/98A priority patent/AU728461B2/en
Priority to DE69830154T priority patent/DE69830154T2/en
Priority to PT98919120T priority patent/PT969815E/en
Priority to EA199900757A priority patent/EA001990B1/en
Priority to BRPI9808060-1A priority patent/BR9808060B1/en
Priority to CO98015975A priority patent/CO4980849A1/en
Priority to SK1299-99A priority patent/SK283417B6/en
Priority to HR980154A priority patent/HRP980154B1/en
Priority to UY24930A priority patent/UY24930A1/en
Priority to ARP980101317A priority patent/AR011697A1/en
Priority to IS5184A priority patent/IS2515B/en
Priority to NO994619A priority patent/NO326719B1/en
Priority to BG103818A priority patent/BG64690B1/en
Priority to HK00102154A priority patent/HK1022853A1/en
Priority to IL13809800A priority patent/IL138098A0/en
Priority to CY0600032A priority patent/CY2569B1/en
Pending legal-status Critical Current

Links

GBGB9706295.4A 1997-03-24 1997-03-26 Lamivudine formulation Pending GB9706295D0 (en)

Priority Applications (45)

Application Number Priority Date Filing Date Title
GBGB9706295.4A GB9706295D0 (en) 1997-03-26 1997-03-26 Lamivudine formulation
TW087103841A TW536403B (en) 1997-03-24 1998-03-16 An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
SK1299-99A SK283417B6 (en) 1997-03-24 1998-03-20 Pharmaceutical composition, process for preparation and use thereof
EEP199900440A EE03996B1 (en) 1997-03-24 1998-03-20 Pharmaceutical compositions, process for their preparation and use
PCT/EP1998/001626 WO1998042321A2 (en) 1997-03-24 1998-03-20 Liquid compositions comprising lamivudine
HN1998000045A HN1998000045A (en) 1997-03-24 1998-03-20 PHARMACEUTICAL COMPOSITIONS
SI9830767T SI0969815T1 (en) 1997-03-24 1998-03-20
ES98919120T ES2239802T3 (en) 1997-03-24 1998-03-20 PHARMACEUTICAL COMPOSITIONS.
EP98919120A EP0969815B1 (en) 1997-03-24 1998-03-20 Pharmaceutical compositions
KR10-1999-7008690A KR100484695B1 (en) 1997-03-24 1998-03-20 Pharmaceutical Compositions
CA002286126A CA2286126C (en) 1997-03-24 1998-03-20 Pharmaceutical compositions
PA19988449301A PA8449301A1 (en) 1997-03-24 1998-03-20 PHARMACEUTICAL COMPOSITIONS
AT98919120T ATE295150T1 (en) 1997-03-24 1998-03-20 PHARMACEUTICAL COMPOSITIONS
CNB988051222A CN1191061C (en) 1997-03-24 1998-03-20 Medical compsns.
PE1998000203A PE61699A1 (en) 1997-03-24 1998-03-20 PHARMACEUTICAL COMPOSITION OF LAMIVUDINE
HU0002982A HU225600B1 (en) 1997-03-24 1998-03-20 Liquid compositions comprising lamivudine
IDW991096A ID29294A (en) 1997-03-24 1998-03-20 PHARMACEUTICAL COMPOSITION
JP54442598A JP3264937B2 (en) 1997-03-24 1998-03-20 Pharmaceutical composition
MYPI98001227A MY116242A (en) 1997-03-24 1998-03-20 Pharmaceutical compositions containing lamivudine .
PL98336038A PL190505B1 (en) 1997-03-24 1998-03-20 Pharmaceutic compositions
SV1998000040A SV1998000040A (en) 1997-03-24 1998-03-20 PHARMACEUTICAL COMPOSITIONS REF. PU3210 / SV
IL13809898A IL138098A (en) 1997-03-24 1998-03-20 Use of lamivudine or pharmaceutically acceptable derivatives thereof for the manufacture of pharmaceutical compositions for use in the treatment or prophylaxis of viral infections
IL13191798A IL131917A0 (en) 1997-03-24 1998-03-20 Pharmaceutical compositions
US09/044,896 US6004968A (en) 1997-03-24 1998-03-20 Pharmaceutical compositions containing lamivudine
DK98919120T DK0969815T3 (en) 1997-03-26 1998-03-20 Pharmaceuticals
CZ0340399A CZ298008B6 (en) 1997-03-24 1998-03-20 Pharmaceutical composition
UA99095237A UA60328C2 (en) 1997-03-26 1998-03-20 Pharmaceutical formulations
APAP/P/1999/001657A AP1141A (en) 1997-03-24 1998-03-20 A pharmaceutical composition comprising lamivudine or its derivatives that can be effectively preserved by parabens.
YUP-477/99A RS49772B (en) 1997-03-24 1998-03-20 Pharmaceutical compositions
NZ337798A NZ337798A (en) 1997-03-24 1998-03-20 Pharmaceutical compositions containing lamivudine
AU72084/98A AU728461B2 (en) 1997-03-24 1998-03-20 Pharmaceutical compositions
DE69830154T DE69830154T2 (en) 1997-03-24 1998-03-20 PHARMACEUTICAL COMPOSITIONS
PT98919120T PT969815E (en) 1997-03-24 1998-03-20 PHARMACEUTICAL COMPOSITIONS
EA199900757A EA001990B1 (en) 1997-03-24 1998-03-20 Pharmaceutical compositions
BRPI9808060-1A BR9808060B1 (en) 1997-03-24 1998-03-20 pharmaceutical composition, and use of lamivudine or a pharmaceutically acceptable derivative thereof.
CO98015975A CO4980849A1 (en) 1997-03-24 1998-03-20 PHARMACEUTICAL COMPOSITIONS -2-HIDROXIMETIL-1,3-OXATIOLAN-5-IL) - (1H) -PIRIMIDIN-2-ONA (LA MIVUDINA), AND ITS USE IN MEDICAL THERAPY
ARP980101317A AR011697A1 (en) 1997-03-24 1998-03-23 PHARMACEUTICAL COMPOSITIONS, USE OF LAMIVUDINE IN THE MANUFACTURE OF SUCH PHARMACEUTICAL COMPOSITIONS.
HR980154A HRP980154B1 (en) 1997-03-24 1998-03-23 Pharmaceutical compositions
UY24930A UY24930A1 (en) 1997-03-24 1998-03-23 PHARMACEUTICAL COMPOSITIONS CONTAINING (2R, CIS) -4-AMINO-1- (2-HIDROXIMETIL-1,3 -OXATIOLAN-5-IL) - (1H) -PIRIMIDIN-2-ONA (LAMIVUDINE)
IS5184A IS2515B (en) 1997-03-24 1999-09-17 pharmaceutical compositions
NO994619A NO326719B1 (en) 1997-03-24 1999-09-23 Pharmaceutical compositions, as well as the use and process for their preparation.
BG103818A BG64690B1 (en) 1997-03-24 1999-10-18 Pharmaceutical compositions
HK00102154A HK1022853A1 (en) 1997-03-24 2000-04-07 Pharmaceutical compositions.
IL13809800A IL138098A0 (en) 1997-03-24 2000-08-25 Use of pharmaceutical compositions containing lamivudine for treating viral infections
CY0600032A CY2569B1 (en) 1997-03-24 2006-11-09 Pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9706295.4A GB9706295D0 (en) 1997-03-26 1997-03-26 Lamivudine formulation

Publications (1)

Publication Number Publication Date
GB9706295D0 true GB9706295D0 (en) 1997-05-14

Family

ID=10809910

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9706295.4A Pending GB9706295D0 (en) 1997-03-24 1997-03-26 Lamivudine formulation

Country Status (3)

Country Link
DK (1) DK0969815T3 (en)
GB (1) GB9706295D0 (en)
UA (1) UA60328C2 (en)

Also Published As

Publication number Publication date
UA60328C2 (en) 2003-10-15
DK0969815T3 (en) 2005-06-27

Similar Documents

Publication Publication Date Title
IL135295A0 (en) 2-methyl-thieno-benzodiazepine formulation
GB9715751D0 (en) Formulations
DE59803915D1 (en) Bandwaage
ZA9811461B (en) New formulation
HK1026429A1 (en) New formulation
DE59803341D1 (en) Handhobelmaschine
DE59803148D1 (en) Dimensionsstabile thermoplastische formmassen
GB9724544D0 (en) Novel Formulation
DE59708342D1 (en) Basophilen-degranulationstest
ZA9810773B (en) Revitalisation formulation
GB9706957D0 (en) Formulation
GB9706295D0 (en) Lamivudine formulation
GB9725275D0 (en) Formulation
GB9721807D0 (en) Formulation
CA80910S (en) Aeroglisseur
CA80915S (en) Elbow-rest
CA82746S (en) Handleset
CA82748S (en) Handleset
CA82745S (en) Handleset
CA80851S (en) Thermomter
CA79884S (en) Moniitor
CA82333S (en) Remorque
CA82218S (en) Sports-glasses
CA81694S (en) Tape-rule
GB9703100D0 (en) Formulations